Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.5 EUR | +2.16% | +4.11% | +0.85% |
Apr. 26 | Mersen: Amiral Gestion below 5% of share capital | CF |
Apr. 24 | Mersen: sales growth of around 7% in Q1 | CF |
Sales 2024 * | 1.27B 1.36B | Sales 2025 * | 1.39B 1.49B | Capitalization | 859M 918M |
---|---|---|---|---|---|
Net income 2024 * | 87M 93.02M | Net income 2025 * | 99M 106M | EV / Sales 2024 * | 0.99 x |
Net Debt 2024 * | 393M 421M | Net Debt 2025 * | 443M 473M | EV / Sales 2025 * | 0.94 x |
P/E ratio 2024 * |
9.87
x | P/E ratio 2025 * |
8.68
x | Employees | 7,423 |
Yield 2024 * |
3.54% | Yield 2025 * |
3.85% | Free-Float | 97.69% |
Latest transcript on Mersen
1 day | +2.16% | ||
1 week | +4.11% | ||
Current month | -2.61% | ||
1 month | -2.47% | ||
3 months | +5.03% | ||
6 months | +17.36% | ||
Current year | +0.85% |
Managers | Title | Age | Since |
---|---|---|---|
Luc Themelin
CEO | Chief Executive Officer | 63 | 92-12-31 |
Director of Finance/CFO | 53 | 98-12-31 | |
Sylvie Guiganti
CTO | Chief Tech/Sci/R&D Officer | - | 17-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Olivier Legrain
CHM | Chairman | 71 | 17-05-17 |
Emmanuel Blot
BRD | Director/Board Member | 38 | 22-05-18 |
Michel Crochon
BRD | Director/Board Member | 72 | 17-05-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 773 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 35.5 | +2.16% | 19,717 |
24-04-25 | 34.75 | +0.72% | 45,889 |
24-04-24 | 34.5 | +0.15% | 16,569 |
24-04-23 | 34.45 | +0.73% | 23,630 |
24-04-22 | 34.2 | +0.29% | 15,494 |
Real-time Euronext Paris, April 26, 2024 at 11:36 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.85% | 917M | |
+11.85% | 869B | |
0.00% | 239B | |
+27.20% | 178B | |
-7.75% | 126B | |
-5.21% | 74.17B | |
-16.00% | 50.82B | |
-24.57% | 38.6B | |
+19.71% | 31.74B | |
+14.46% | 29.82B |
- Stock Market
- Equities
- MRN Stock